With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S ...

Intuitive Surgical shares climbed in late trading Thursday after the company reported fourth-quarter profit ...

Polen Capital Management Llc released its “Polen Focus Growth Strategy” Q4 2025 investor letter. A copy of the letter can be ...

The FDA 510(k) clearances for cardiac procedures cover Intuitive's latest-generation da Vinci 5 (DV5) using non-Force ...

Soft tissue robotic systems designed to improve surgical precision are expanding into new specialties and increasing ...

Investing.com -- TD Cowen initiated coverage of Intuitive Surgical with a Buy rating and a $660 price target, saying the launch of the da Vinci 5 system is driving a long-tailed product cycle that can ...

Intuitive Surgical capped off the recovery in its shares with a strong Q4 2025 earnings release, lending support to the stock ...

If you are wondering whether Intuitive Surgical at around US$525 a share still makes sense for your portfolio, the key ...

Intuitive CEO Dave Rosa highlighted that the clearance related to “several cardiac” procedures for non-force instruments used ...

Intuitive Surgical Inc (NASDAQ:ISRG) reports financial results for the fourth quarter on Thursday. Here's a rundown of the ...

Intuitive Surgical reported revenue of $2.87 billion for the fourth quarter, beating analyst estimates of $2.75 billion, ...

Dan Larson, a Seattle resident diagnosed with lung cancer in 2023, benefited from robotic-assisted surgery developed by Intuitive, a leader in robotic surgical technology. After undergoing two robotic ...